Get started
Author

Pasquale Russomanno

Observed names: Pasquale Russomano, Russomanno, Pasquale
ORCID: 0000-0002-0236-1200
Observed ORCID: 0000-0002-0236-1200
OpenAlex ID: A5081443257
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer’s Disease
2019 · Angela De Simone, Valeria La Pietra, et al. · ACS Medicinal Chemistry Letters · 60
New biologic (Ab-IPL-IL-17) for IL-17-mediated diseases: identification of the bioactive sequence (nIL-17) for IL-17A/F function
2023 · Anella Saviano, Adel Abo Manosour, et al. · Annals of the Rheumatic Diseases · 33
PDF
Interfering with the Tumor–Immune Interface: Making Way for Triazine-Based Small Molecules as Novel PD-L1 Inhibitors
2021 · Pasquale Russomanno, Giulia Assoni, et al. · Journal of Medicinal Chemistry · 32
Targeting the KRAS oncogene: Synthesis, physicochemical and biological evaluation of novel G-Quadruplex DNA binders
2020 · Federica D'Aria, Vincenzo Maria D'Amore, et al. · European Journal of Pharmaceutical Sciences · 32
CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiforme
2021 · Simona Daniele, Valeria La Pietra, et al. · European Journal of Pharmacology · 23
PDF
A First-in-Class Pyrazole-isoxazole Enhanced Antifungal Activity of Voriconazole: Synergy Studies in an Azole-Resistant Candida albicans Strain, Computational Investigation and in Vivo Validation in a Galleria mellonella Fungal Infection Model
2024 · Sveva Pelliccia, Pasquale Russomanno, et al. · Journal of Medicinal Chemistry · 14
PDF
Expanding the Functions of KHSRP Protein: Insights into DNA G‐Quadruplex Binding
2025 · Pasquale Russomanno, Pasquale Zizza, et al. · Advanced Science · 11
PDF
Theoretical and experimental studies on the interaction of biphenyl ligands with human and murine PD-L1: Up-to-date clues for drug design
2023 · Greta Donati, Vincenzo Maria D’Amore, et al. · Computational and Structural Biotechnology Journal · 9
PDF
Cytosine epigenetic modifications and conformational changes in G‐quadruplex DNA: An ultraviolet resonance Raman spectroscopy study
2023 · Francesco D'Amico, Raffaele Graziano, et al. · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · 8
Discovery of 2,3-Diaminoindole Derivatives as a Novel Class of NOD Antagonists
2024 · Camilla Russo, Pasquale Russomanno, et al. · Journal of Medicinal Chemistry · 7
HOPPI-NMR: Hot-Peptide-Based Screening Assay for Inhibitors of Protein–Protein Interactions by NMR
2020 · Diego Brancaccio, Salvatore Di Maro, et al. · ACS Medicinal Chemistry Letters · 7
A combined approach of structure‐based virtual screening and NMR to interrupt the PD‐1/PD‐L1 axis: Biphenyl‐benzimidazole containing compounds as novel PD‐L1 inhibitors
2023 · Greta Donati, Monica Viviano, et al. · Archiv der Pharmazie · 6
PDF
Sustainable Joullié–Ugi and Continuous Flow Implementation Led to Novel Captopril-Inspired Broad-Spectrum Metallo-β-Lactamase Inhibitors
2025 · Antonella Ilenia Alfano, Sveva Pelliccia, et al. · Journal of Medicinal Chemistry · 5
Coupling PD-L1 Inhibition and Lysosomal Degradation: Innovative Anti-PD-L1 Peptides for NSCLC Immunotherapy
2026 · Francesco Merlino, Valentina Pagliara, et al. · Journal of Medicinal Chemistry · 4
Two Sides of the Same Coin: Transthyretin (TTR) as a Target or Drug Carrier for Drug (Bio)conjugates
2026 · Pasquale Russomanno, Marco Fragai, et al. · Journal of Medicinal Chemistry · 2
Deciphering the RNA recognition by Musashi-1 to design protein and RNA variants for in vitro and in vivo applications
2025 · Anna Pérez-Ràfols, Guillermo Pérez-Ropero, et al. · Nucleic Acids Research · 2
PDF
NMR Assessment of the High Order Structure of Biological Therapeutics in Erythrocytes Provides a Tool for Drug Delivery Design
2025 · Luis Padilla-Cortés, Giulia Roxana Gheorghita, et al. · Journal of the American Chemical Society · 1
PDF
Characterization of Full‐Length Antibody Complexes Through HDX‐Mass Spectrometry Coupled With NMR Spectroscopy: New Insight Into Avelumab/PD‐L1 Interaction
2026 · Francesca Sacco, Fabio Baroni, et al. · Angewandte Chemie
Characterization of Full‐Length Antibody Complexes Through HDX‐Mass Spectrometry Coupled With NMR Spectroscopy: New Insight Into Avelumab/PD‐L1 Interaction
2026 · Francesca Sacco, Fabio Baroni, et al. · Angewandte Chemie International Edition
PDF
Deciphering RNA Recognition by Musashi-1 for Protein and RNA Design
2026 · Russomanno, Pasquale
Non-Covalent N-Glycan-Directed Paramagnetic Tagging: Structural Analysis of Glycoproteins by NMR
2026 · Francesco Milanesi, Ricardo José Faria Pereira, et al. · Florence Research (University of Florence)
NS2B-NS3 protease as a target for anti-flaviviral therapeutics: Expression and NMR assignment of proteins from pathogenic strains for drug screening
2026 · Ricardo Jose Faria Pereira, Rebecca Calamandrei, et al. · Florence Research (University of Florence)
Expression and purification of soluble human KHSPR using E. Coli system
2022 · Pasquale Russomanno
Design of Small Molecules with Antitumor Activity through Computational Methodologies
2021 · Russomanno, Pasquale
Correction to “Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer’s Disease”
2019 · Angela De Simone, Valeria La Pietra, et al. · ACS Medicinal Chemistry Letters
PDF
Works count: 28
Citation count: 256
H-index: 8
I10-index: 7
Year
Topic
Type